Exploring the Therapeutic Potential of TGF-Beta Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways
July 2025
in “
Journal of Clinical and Translational Hepatology
”
Studysummary This review discusses how targeting TGF-β with specific inhibitors, including components from Traditional Chinese Medicine, may help reduce liver fibrosis by acting through various signaling pathways.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on publinestorage.blob.core.windows.net →